(0.02%) 5 071.63 points
(-0.11%) 38 461 points
(0.10%) 15 713 points
(-0.24%) $82.61
(0.73%) $1.665
(-0.34%) $2 330.50
(-0.44%) $27.23
(-0.44%) $911.80
(-0.07%) $0.934
(-0.03%) $10.98
(-0.02%) $0.802
(0.00%) $92.32
Quarter results today
(bmo 2024-04-25)
Expected move: +/- 6.09%
Live Chart Being Loaded With Signals
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific...
Stats | |
---|---|
Today's Volume | 757 263 |
Average Volume | 534 512 |
Market Cap | 28.24B |
EPS | $0 ( 2024-02-15 ) |
Next earnings date | ( $1.290 ) 2024-04-25 |
Last Dividend | $0.200 ( 2023-11-07 ) |
Next Dividend | $0 ( N/A ) |
P/E | 48.95 |
ATR14 | $0.372 (0.10%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-11 | Winters Chad | Buy | 675 | Common Stock |
2024-03-11 | Winters Chad | Sell | 815 | Common Stock |
2024-03-11 | Winters Chad | Sell | 675 | Stock Options (Right to Buy) |
2024-02-28 | Witherspoon Charles | Buy | 2 019 | Common Stock |
2024-02-28 | Witherspoon Charles | Sell | 2 019 | Common Stock |
INSIDER POWER |
---|
-18.71 |
Last 100 transactions |
Buy: 252 782 | Sell: 384 704 |
Volume Correlation
West Pharmaceutical Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
West Pharmaceutical Correlation - Currency/Commodity
West Pharmaceutical Financials
Annual | 2023 |
Revenue: | $2.95B |
Gross Profit: | $1.13B (38.28 %) |
EPS: | $7.99 |
Q4 | 2023 |
Revenue: | $732.00M |
Gross Profit: | $278.20M (38.01 %) |
EPS: | $1.850 |
Q3 | 2023 |
Revenue: | $747.40M |
Gross Profit: | $288.30M (38.57 %) |
EPS: | $2.17 |
Q2 | 2023 |
Revenue: | $753.80M |
Gross Profit: | $291.40M (38.66 %) |
EPS: | $2.09 |
Financial Reports:
No articles found.
West Pharmaceutical Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.180 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.190 (N/A) |
$0.200 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0163 | 1987-01-26 |
Last Dividend | $0.200 | 2023-11-07 |
Next Dividend | $0 | N/A |
Payout Date | 2023-11-15 | |
Next Payout Date | N/A | |
# dividends | 148 | -- |
Total Paid Out | $11.05 | -- |
Avg. Dividend % Per Year | 0.18% | -- |
Score | 5.41 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.67 | |
Div. Directional Score | 9.46 | -- |
Year | Amount | Yield |
---|---|---|
1987 | $0.0676 | 1.90% |
1988 | $0.0726 | 1.70% |
1989 | $0.0776 | 1.97% |
1990 | $0.100 | 2.12% |
1991 | $0.100 | 3.30% |
1992 | $0.100 | 2.19% |
1993 | $0.103 | 1.82% |
1994 | $0.113 | 1.84% |
1995 | $0.123 | 1.79% |
1996 | $0.133 | 2.23% |
1997 | $0.143 | 2.04% |
1998 | $0.153 | 2.06% |
1999 | $0.163 | 1.86% |
2000 | $0.173 | 2.28% |
2001 | $0.183 | 2.98% |
2002 | $0.190 | 2.85% |
2003 | $0.203 | 3.29% |
2004 | $0.213 | 2.49% |
2005 | $0.225 | 1.78% |
2006 | $0.245 | 1.89% |
2007 | $0.265 | 1.04% |
2008 | $0.285 | 1.41% |
2009 | $0.305 | 1.60% |
2010 | $0.325 | 1.65% |
2011 | $0.345 | 1.65% |
2012 | $0.365 | 1.91% |
2013 | $0.385 | 1.39% |
2014 | $0.410 | 0.84% |
2015 | $0.450 | 0.86% |
2016 | $0.490 | 0.85% |
2017 | $0.530 | 0.63% |
2018 | $0.570 | 0.57% |
2019 | $0.610 | 0.63% |
2020 | $0.650 | 0.43% |
2021 | $0.690 | 0.24% |
2022 | $0.730 | 0.16% |
2023 | $0.770 | 0.33% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
MTR | Dividend Diamond | 2023-10-30 | Monthly | 39 | 10.10% | 8.50 |
SBR | Dividend Royal | 2023-11-14 | Monthly | 38 | 7.74% | 8.50 |
PDI | Dividend Royal | 2023-11-10 | Monthly | 13 | 7.86% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.201 | 1.500 | 5.98 | 8.97 | [0 - 0.5] |
returnOnAssetsTTM | 0.155 | 1.200 | 4.83 | 5.80 | [0 - 0.3] |
returnOnEquityTTM | 0.211 | 1.500 | 8.77 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.0961 | -1.000 | 9.04 | -9.04 | [0 - 1] |
currentRatioTTM | 2.88 | 0.800 | 0.588 | 0.470 | [1 - 3] |
quickRatioTTM | 2.03 | 0.800 | 2.75 | 2.20 | [0.8 - 2.5] |
cashRatioTTM | 1.271 | 1.500 | 4.05 | 6.07 | [0.2 - 2] |
debtRatioTTM | 0.0807 | -1.500 | 8.66 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 75.11 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 10.48 | 2.00 | 6.51 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.59 | 2.00 | 7.20 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.107 | -1.500 | 9.57 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.383 | 1.000 | 6.95 | 6.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.229 | 1.000 | 7.42 | 7.42 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 2.51 | 1.000 | 10.00 | 10.00 | [0.2 - 2] |
assetTurnoverTTM | 0.770 | 0.800 | 8.20 | 6.56 | [0.5 - 2] |
Total Score | 12.25 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 48.73 | 1.000 | 5.18 | 0 | [1 - 100] |
returnOnEquityTTM | 0.211 | 2.50 | 9.21 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.59 | 2.00 | 8.14 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.251 | 1.500 | 3.72 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 10.48 | 2.00 | 6.51 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.0961 | 1.500 | 9.04 | -9.04 | [0 - 1] |
pegRatioTTM | 4.36 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.263 | 1.000 | 5.92 | 0 | [0.1 - 0.5] |
Total Score | 6.67 |
West Pharmaceutical
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators